# Ketamine Treatment Effects on Synaptic Plasticity in Depression

> **NCT04091971** · PHASE4 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 9 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT04091971
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-09
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04091971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04091971, "Ketamine Treatment Effects on Synaptic Plasticity in Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04091971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*